Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | CES1 | P23141 | 4/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | KDM5A | P29375 | 2/20 | 0.42 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ICMT | O60725 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13270009 | 1.00 | CES2 (0.44) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL29470959 | 1.00 | CES2 (0.44) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL4210961 | 1.00 | CES2 (0.44) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL28869538 | 1.00 | CES2 (0.44) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL28420309 | 0.98 | CES2 (0.42) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL15809341 | 0.96 | CES2 (0.41) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL25509010 | 0.96 | KDM5A (0.44) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL8386144 | 0.94 | CES2 (0.39) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL1777056 | 0.91 | CA1 (0.46) | CES2CES1SOAT1MEN1FAAH | |
| SCHEMBL8383111 | 0.89 | KDM5A (0.41) | CES2CES1SOAT1MEN1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115368264-B | Compounds, liposomes and uses thereof | 北京理工大学 | 2025-03-07 | — | — | CN | claimed |
| CN-118252815-A | Cell membrane coated nucleic acid lipid composite nanoparticle and preparation method and application thereof | 杭州纽安津生物科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-114099699-B | Nanometer delivery system and preparation method and application thereof | 华南理工大学 | 2024-03-19 | — | — | CN | claimed |
| CN-112791192-B | Inflammatory cell targeted melittin liposome nano preparation and preparation method and application thereof | 上海交通大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115671045-A | Non-liver-targeting nucleic acid nano preparation and preparation method and application thereof | 华南理工大学 | 2023-02-03 | — | — | CN | claimed |
| CN-115531617-A | Stomach fistulization catheter coated with lipid polysaccharide compound | 上海市徐汇区大华医院 | 2022-12-30 | — | — | CN | claimed |
| CN-115414536-A | Gene elution balloon and preparation method and application thereof | 苏州中天医疗器械科技有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-115368264-A | Compound, liposome and application thereof | 北京理工大学 | 2022-11-22 | — | — | CN | claimed |
| CN-111701029-B | Up-conversion bionic complex, preparation method and application of weak ultraviolet conversion | 济南康硕生物技术有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-114540416-A | Expression vector, lipid nanoparticle, antitumor drug, preparation method and application thereof | 上海交通大学 | 2022-05-27 | — | — | CN | claimed |
| CN-114053225-A | High-efficiency low-toxicity and good-stability cationic liposome for gene delivery and application thereof | 浙江大学 | 2022-02-18 | — | — | CN | claimed |
| CN-112791192-A | Inflammatory cell targeted melittin liposome nano preparation and preparation method and application thereof | 上海交通大学 | 2021-05-14 | — | — | CN | claimed |
| CN-115368264-B | Compounds, liposomes and uses thereof | 北京理工大学 | 2025-03-07 | — | — | CN | disclosed |
| CN-118284692-A | Gene editing of PCSK9 or ANGPTL3 and compositions and methods of using same for treating diseases | 维乎医疗有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118108847-A | MRNA mediated immune method | 诺华股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-115304756-B | Five-membered lipid nanoparticle as well as preparation method and application thereof | 上海科技大学 | 2023-05-09 | — | — | CN | disclosed |
| CN-113855634-A | Polypeptide-modified liposome, mRNA (messenger ribonucleic acid) delivery system and dendritic cell vaccine | 四川大学 | 2021-12-31 | — | — | CN | disclosed |
| CN-113332264-A | Composition containing sophora flavescens extract for pulmonary administration and preparation method and application thereof | 贵州医科大学 | 2021-09-03 | — | — | CN | disclosed |
| CN-109562153-A | mRNA mediated immunization methods | 诺华股份有限公司 | 2019-04-02 | — | — | CN | disclosed |
| US-20100297023-A1 | Lipid | IMUTHES LIMITED UNIVERSITY OF THE WITWATERSRAND | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297023-A1 | Lipid | NR1H2, NR1H3, NR1H4 | CES2 871/4885CES1 394/4885SOAT1 636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.